A Study to Evaluate the Efficacy and Safety of TL118 in Solid Tumors Patients
Clinical trial NCT06010342 · RECRUITING
Trial details
- NCT number
- NCT06010342
- Sponsor
- Teligene US
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-16
- Primary completion
- 2027-12-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.